Sciphage

Sciphage is a biotech company founded in 2014, which focuses on the development of phage-based products to control Salmonella in chicken farms. The company's slogan "We improve animal and human health, through our phage-based technology, reducing pathogens and antibiotics use," underscores their commitment to addressing critical issues in animal and human health. Specializing in analytics, biotechnology, and sustainability, Sciphage stands at the forefront of innovative solutions in the biotech industry.

With a clear focus on pathogen reduction and decreasing reliance on antibiotics, Sciphage presents an appealing opportunity for venture capital investment. While details about the company's headquarters and recent investments are not available, the potential for positive impact on the agricultural and healthcare sectors positions Sciphage as a promising investment prospect.